Cenk Sumen, Chief Technology Officer 

Oct. 12 | 4:45pm | Oxford Biomedica Ballroom 

Gaithersburg, MD 


In-person Presentation 

MaxCyte® is a leading provider of cell-engineering platform technologies and is responsible for helping to bring next‐generation cell-based therapies to life. The company’s technology is employed by leading drug developers worldwide, including 20 of the top 25 global biopharmaceutical companies. Our Flow Electroporation® technology and next-generation ExPERT™ platform enable our partners to accelerate, streamline, and improve the drug development process from the early stages of research to commercialization. 

By using this website you agree to accept our Privacy Policy and Terms & Conditions